EGFRi Combinations

NSCLC
» ENCORE-401, entinostat (SNDX-275) with Erlotinib

AI Combinations

Breast Cancer
» ENCORE-301, entinostat (SNDX-275) with Exemestane
» ENCORE-303, entinostat (SNDX-275) with Aromatase Inhibitors

DNA Methyltransferase Inhibitor Combinations

NSCLC
» entinostat (SNDX-275) with Azacitidine

Colorectal Cancer
» entinostat (SNDX-275) with Azacitidine

MDS, Chronic Myelomonocytic Leukemia, and/or AML
» entinostat (SNDX-275) with or without Azacitidine

Growth Factor Combinations

Renal Cell Carcinoma
» entinostat (SNDX-275) with Interleukin 2 and Aldesleukin

MDS, Chronic Myelomonocytic Leukemia, and/or AML
» entinostat (SNDX-275) and GM-CSF (NCI)

Other Combination Studies

Acute Lymphoblastic Leukemia (ALL)
» entinostat (SNDX-275) and Clofarabine

Single Agent Studies

Hodgkins Lymphoma
» ENGAGE-501, entinostat (SNDX-275)